Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -2.37%35.77B | -1.90%177.85B | -0.59%133.44B | -0.23%83.28B | -1.04%36.64B | -13.76%181.3B | -15.88%134.23B | -18.46%83.47B | -16.22%37.02B | -10.12%210.22B |
| Operating income | -2.37%35.77B | -1.90%177.85B | -0.59%133.44B | -0.23%83.28B | -1.04%36.64B | -13.76%181.3B | -15.88%134.23B | -18.46%83.47B | -16.22%37.02B | -10.12%210.22B |
| Cost of sales | ---- | 2.69%-144.6B | ---- | 4.15%-67.3B | ---- | 13.99%-148.59B | ---- | 17.17%-70.22B | ---- | 10.96%-172.77B |
| Operating expenses | 1.50%-29.26B | 2.69%-144.6B | 3.32%-105.57B | 4.15%-67.3B | 4.16%-29.71B | 13.99%-148.59B | 15.53%-109.19B | 17.17%-70.22B | 16.75%-31B | 10.96%-172.77B |
| Gross profit | -6.12%6.5B | 1.66%33.25B | 11.33%27.88B | 20.57%15.98B | 15.06%6.93B | -12.65%32.71B | -17.39%25.04B | -24.72%13.25B | -13.37%6.02B | -6.02%37.45B |
| Selling expenses | 10.30%-930.53M | -5.70%-4.14B | 1.49%-2.92B | -1.95%-1.93B | -10.74%-1.04B | -6.06%-3.92B | -4.04%-2.96B | -4.38%-1.89B | -2.65%-936.73M | -1.73%-3.69B |
| Administrative expenses | -1.54%-3.24B | -31.99%-27.22B | 3.95%-9.52B | 9.88%-8.93B | -0.26%-3.19B | 2.36%-20.62B | -0.25%-9.91B | -4.59%-9.91B | 1.81%-3.18B | -0.56%-21.12B |
| Research and development expenses | 11.27%-906.92M | ---- | 7.88%-4.04B | ---- | 4.05%-1.02B | ---- | 4.38%-4.38B | ---- | -0.94%-1.07B | ---- |
| Profit from asset sales | 609.41%382.65M | ---- | 539.59%97.73M | ---- | -22.31%53.94M | ---- | -59.68%15.28M | ---- | 724.12%69.42M | ---- |
| Revaluation surplus | 325.83%142.46M | ---- | 554.49%333.33M | ---- | 16.47%-63.08M | ---- | 90.57%-73.34M | ---- | -409.38%-75.52M | ---- |
| -Changes in the fair value of other assets | 325.83%142.46M | ---- | 554.49%333.33M | ---- | 16.47%-63.08M | ---- | 90.57%-73.34M | ---- | -409.38%-75.52M | ---- |
| Impairment and provision | 167.09%21.23M | -226.48%-2.06B | -151.19%-662.39M | -121.41%-433.36M | -670.63%-31.65M | -1,010.22%-629.68M | -33.39%-263.7M | 24.95%-195.72M | 32.03%5.55M | 350.97%69.18M |
| -Other impairment is provision | 167.09%21.23M | -226.48%-2.06B | -151.19%-662.39M | -121.41%-433.36M | -670.63%-31.65M | -1,010.22%-629.68M | -33.39%-263.7M | 24.95%-195.72M | 32.03%5.55M | 350.97%69.18M |
| Special items of operating profit | -16.38%559.63M | ---- | 34.87%2.68B | ---- | 37.60%669.25M | ---- | -8.56%1.99B | ---- | -15.39%486.38M | ---- |
| Operating profit | 14.05%1.87B | -102.23%-167.8M | 61.39%11.49B | 274.24%4.68B | 136.65%1.64B | -40.65%7.54B | -38.64%7.12B | -79.33%1.25B | -56.72%694.52M | -16.34%12.7B |
| Financing cost | ---- | 6.74%-4.34B | ---- | 6.38%-2.29B | ---- | 9.42%-4.66B | ---- | 8.18%-2.44B | ---- | 12.99%-5.14B |
| Share of profits of associates | ---- | -21.77%853.47M | ---- | 99.49%680.22M | ---- | -27.87%1.09B | ---- | -65.88%340.98M | ---- | -50.37%1.51B |
| Share of profit from joint venture company | ---- | 166.93%6.64M | ---- | 21.17%-5.51M | ---- | -195.38%-9.91M | ---- | -75.14%-6.99M | ---- | 56.24%-3.36M |
| Special items of earning before tax | 586.94%49.34M | -12.92%4.82B | 8.31%-36.03M | 73.50%2.05B | 49.85%-10.13M | 60.20%5.53B | -115.74%-39.3M | 2.37%1.18B | -117.76%-20.2M | -39.40%3.45B |
| Earning before tax | 62.58%756.1M | -87.71%1.17B | 170.89%8.11B | 1,466.48%5.13B | 161.17%465.05M | -24.17%9.49B | -61.39%2.99B | -94.10%327.2M | -402.77%-760.26M | -30.48%12.52B |
| Tax | ---- | -0.39%-2.09B | ---- | -87.34%-1.16B | ---- | 1.86%-2.08B | ---- | 45.21%-619.55M | ---- | 18.69%-2.12B |
| After-tax profit from continuing operations | 294.92%401.33M | -112.42%-920.87M | 243.63%6.57B | 1,456.17%3.96B | 111.02%101.62M | -28.72%7.41B | -70.20%1.91B | -106.62%-292.35M | -3,268.06%-922.27M | -32.48%10.4B |
| Earning after tax | 294.92%401.33M | -112.42%-920.87M | 243.63%6.57B | 1,456.17%3.96B | 111.02%101.62M | -28.72%7.41B | -70.20%1.91B | -106.62%-292.35M | -3,268.06%-922.27M | -32.48%10.4B |
| Minority profit | -6.42%578.75M | -46.27%2.42B | 39.07%3.61B | 64.10%2.39B | 44.75%618.47M | -24.62%4.51B | -36.10%2.6B | -47.00%1.46B | -14.33%427.27M | -9.10%5.99B |
| Special items of profit attributable to shareholders | ---- | -22.20%400.19M | ---- | -19.79%216.67M | ---- | -6.78%514.42M | ---- | 2.18%270.13M | ---- | -19.86%551.81M |
| Profit attributable to shareholders | 65.67%-177.43M | -256.88%-3.75B | 532.46%2.96B | 167.42%1.36B | 61.70%-516.85M | -38.20%2.39B | -129.08%-684.38M | -243.69%-2.02B | -156.49%-1.35B | -52.48%3.86B |
| Basic earnings per share | -270.67%-0.483 | 171.97%0.172 | -38.21%0.283 | -243.98%-0.239 | -52.49%0.458 | |||||
| Diluted earnings per share | -270.67%-0.483 | 171.97%0.172 | -37.11%0.283 | -243.98%-0.239 | -53.32%0.45 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.